Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma

Journal of Clinical Oncology

Volumn 9, Issue 6, 1991, Pages 1050-1058

  Cheung, Nai Kong V ^a   Heller, Glenn ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; CHILD; CONTROLLED STUDY; DRUG DOSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROBLASTOMA; PRIORITY JOURNAL; REVIEW; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMAN; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUROBLASTOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TENIPOSIDE; VINCRISTINE;

EID: 0025758201     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1991.9.6.1050     Document Type: Article

References (18)

1. Kushner BH, Cheung NKV: Treatment of neuroblastoma, in DeVita VT, Hellman S, Rosenberg SA, (eds): Cancer Principles and Practice: Updates (vol 2). Philadelphia, PA, Lippencott, 1988, pp 1-11
2. Frei E, Canellos GP: Dose: A critical factor in cancer chemotherapy. Am J Med 69:585-594, 1980
3. Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281-1288, 1984
4. Levin L, Hryniuk WM: Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol 5:756-767, 1987
5. Longo DL, Young RC, Wesley M, et al: Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol 4:1295-1306, 1986
6. DeVita VT, Hubbard MS, Young RC, et al: The role of chemotherapy in diffuse aggressive lymphomas. Semin Hematol 25:2-10, 1988
7. Carli M, Green AA, Hayes FA, et al: Therapeutic efficacy of single drugs for childhood neuroblastoma: A review, in Raybaud C, Clement R, Lebreuil G, et al (eds): Proceedings, XIII Meeting of the International Society of Pediatric Oncology, ICS 570. Amsterdam, The Netherlands, Excerpta Medica, 1982, pp 141-150
8. Hartmann JR: Chemotherapy of metastatic neuroblastoma. J Pediatr Surg 3:181-182, 1968
9. Pinkel D, Pratt C, Holton C, et al: Survival of children with neuroblastoma treated with combination chemotherapy. J Pediatr 73:928-931, 1968
10. Sullivan M, Nora AH, Kulapongs P, et al: Evaluation of vincristine sulfate and cyclophosphamide chemotherapy for metastatic neuroblastoma. Pediatrics 44:685-694, 1969
11. Evans AE, Heyn RM, Newton WA, et al: Vincristine sulfate and cyclophosphamide for children with metastatic neuroblastoma. J Am Med Assoc 207:1325-1327, 1969
12. Helson L, Vanichayangkul P, Tan CC, et al: Combination intermittent chemotherapy for patients with disseminated neuroblastoma. Cancer Chemo Rep 56:499-503, 1972
13. Starling KA, Sutow WW, Donaldson MH, et al: Drug trials in neuroblastoma: Cyclophosphamide (NSC-26271) alone; vincristine (NSC-67574) plus Cyclophosphamide: 6-mercaptopurine (NSC-755) plus 6-methylmercaptopurine riboside (NSC-40774); and cytosine arabinoside (NSC-63878) alone. Cancer Chemo Rep 58:683-688, 1974
14. Gasparini M, Bellani FF, Musumeci R, et al: Re sponse and survival of patients with metastatic neuroblastoma after combination chemotherapy with Adriamycin (NSC-123127), Cyclophosphamide (NSC-26271 ), and vincristine (NSC-67574). Cancer Chemo Rep 58:365-370, 1974
15. Green AA, Hustu HO, Palmer R, et al: Total body sequential segmental irradiation and combination chemotherapy for children with disseminated neuroblastoma Cancer 38:2250-2257, 1976
16. Nesbit ME, Kersey J, Finklestein J, et al: Immunother apy and chemotherapy in children with neuroblastoma. J Natl Cancer Inst 57:717-720, 1976
17. Necheles TF, Rausen AR, Kung FH, et al: Immunochemotherapy in advanced neuroblastoma. Cancer 41:1282-1288, 1978
18. Doering EJ, Nitschke R, Haggard ME, et al: Phase II study demonstrating failure of both a five-drug continuous-therapy regimen and a two-drug pulse-therapy regimen in the treatment of metastatic neuroblastoma: Southwest Oncology Group study 822. Cancer Treat Rep 63:1383-1384, 1979